1. Home
  2. HBIO vs DARE Comparison

HBIO vs DARE Comparison

Compare HBIO & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.69

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$1.98

Market Cap

27.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
DARE
Founded
1901
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
27.6M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
HBIO
DARE
Price
$0.69
$1.98
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$2.50
$10.00
AVG Volume (30 Days)
555.1K
313.4K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$87,371,000.00
N/A
Revenue This Year
N/A
$3,838.11
Revenue Next Year
$7.22
$8,711.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.61
52 Week High
$2.28
$9.19

Technical Indicators

Market Signals
Indicator
HBIO
DARE
Relative Strength Index (RSI) 50.05 46.43
Support Level $0.64 $2.05
Resistance Level $0.80 $2.08
Average True Range (ATR) 0.04 0.14
MACD -0.01 -0.03
Stochastic Oscillator 25.32 9.68

Price Performance

Historical Comparison
HBIO
DARE

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: